---
title: "InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases | IFRX Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285377138.md"
description: "InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases | IFRX Stock News"
datetime: "2026-05-06T04:25:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285377138.md)
  - [en](https://longbridge.com/en/news/285377138.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285377138.md)
---

# InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases | IFRX Stock News

InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases | IFRX Stock News

### Related Stocks

- [IFRX.US](https://longbridge.com/en/quote/IFRX.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)

## Related News & Research

- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)
- [Eton Pharmaceuticals Adds Another 2026 Launch As It Secures U.S. Rights To IMPAVIDO](https://longbridge.com/en/news/287025596.md)
- [Candel Therapeutics Reports Positive Phase 3 Prostate Cancer Trial Data](https://longbridge.com/en/news/286652611.md)
- [Biogen Conference: Lupus, Kidney Programs Take Center Stage in Immunology Push](https://longbridge.com/en/news/286623100.md)
- [Zydus buys US specialty drugmaker Assertio in Rs 1,600 crore all-cash deal](https://longbridge.com/en/news/286352725.md)